.png)
Known Medicine Partners with Duke University to Predict Lung Cancer Response to Drug Treatments
More ↗Known Medicine — 2021 Year in Review
This past year was one of learning, growing, and finding success at Known Medicine.
More ↗Known Medicine Raises $7.2 Million Seed Round to Advance Data First Approach to Organoid Technology
Known Medicine today announced the closure of its seed round of funding in the amount of $7.2 million
More ↗Known Medicine CEO, Dr. Andrea Mazzocchi, discusses the future of lung cancer precision medicine on Lungcast™
The co-founder and CEO of Known Medicine dissects the art and science of how profiling biomarkers, epigenetics and the microenvironment may provide the synergy needed to revolutionize the oncologic la
More ↗CEO Andrea Mazzocchi discusses women in innovative sciences with ABC 4 News
IN FOCUS Discussion: Women in innovative science
More ↗Known Medicine Shows its BioHive Pride
Known Medicine is creating the world’s largest purpose-built 3D cell culture data set to predict the best drug for every cancer patient and create the best drug for every cancer.
More ↗Cancer Precision Medicine — Taking the experiment out of the patient
Precision medicine is the use of a patient’s own tissue, health records, or data to make healthcare related decisions. This can be something as common as the use of a saliva sample to learn more about
More ↗Building a Useful Biological Dataset
The purpose of science is to explain the natural world. The purpose of machine learning, or at least the most common use, is to allow us...
More ↗Here are the 98 companies from Y Combinator’s Summer 2020 Demo Day 1
Today was part one of Y Combinator’s two-parter Summer 2020 Demo Day, where nearly 100 companies debuted their efforts to the world for the first time.
More ↗
